PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR

V. Cozzi, C. Garlanda, M. Nebuloni, V. Maina, A. Martinelli, S. Calabrese, I. Cetin

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Endothelial dysfunction typical of preeclampsia (PE) is the result of an excessive maternal inflammatory response to pregnancy. We investigated PTX3 in maternal, fetal and placental compartments in complicated pregnancies. Maternal blood samples were collected during the third trimester in 53 PE, 43 IUGR (intrauterine growth restriction) and 50 normal pregnancies. Fetal samples were collected from the umbilical vein in 26 PE, 23 IUGR and 26 normal pregnancies at elective cesarean section. Pattern and site of expression of PTX3 were studied by immunohistochemistry (IHC) on placenta, decidual bed and maternal peritoneum. PE and IUGR pregnancies had significantly higher maternal PTX3 levels compared to normal pregnancies, with IUGR significantly lower than PE. Maternal peritoneum expressed a significantly higher signal in the endothelium of pathological compared to normal pregnancies. The maternal increase of PTX3 correlated with the severity of disease with higher PTX3 concentrations in severe PE. Increased PTX3 levels in PE and IUGR mothers, together with IHC data represent the expression of altered endothelial function on the maternal side. IUGR fetuses had higher PTX3 values than controls and the increase was related to IUGR severity, likely reflecting the hypoxic environment. These data confirm the relevance of PTX3 in support the hypothesis that PE is a disease associated with altered maternal endothelial function. The PTX3 increase in IUGR fetuses deserves further investigation.

Original languageEnglish
Pages (from-to)1039-1044
Number of pages6
JournalPlacenta
Volume33
Issue number12
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Pre-Eclampsia
Biomarkers
Mothers
Growth
Pregnancy
Peritoneum
Fetus
Immunohistochemistry
Umbilical Veins
Third Pregnancy Trimester
Cesarean Section
Placenta
Endothelium

Keywords

  • Endothelial dysfunction
  • Fetus
  • Intrauterine growth restriction
  • Preeclampsia
  • PTX3

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine
  • Developmental Biology

Cite this

Cozzi, V., Garlanda, C., Nebuloni, M., Maina, V., Martinelli, A., Calabrese, S., & Cetin, I. (2012). PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR. Placenta, 33(12), 1039-1044. https://doi.org/10.1016/j.placenta.2012.09.009

PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR. / Cozzi, V.; Garlanda, C.; Nebuloni, M.; Maina, V.; Martinelli, A.; Calabrese, S.; Cetin, I.

In: Placenta, Vol. 33, No. 12, 12.2012, p. 1039-1044.

Research output: Contribution to journalArticle

Cozzi, V, Garlanda, C, Nebuloni, M, Maina, V, Martinelli, A, Calabrese, S & Cetin, I 2012, 'PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR', Placenta, vol. 33, no. 12, pp. 1039-1044. https://doi.org/10.1016/j.placenta.2012.09.009
Cozzi, V. ; Garlanda, C. ; Nebuloni, M. ; Maina, V. ; Martinelli, A. ; Calabrese, S. ; Cetin, I. / PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR. In: Placenta. 2012 ; Vol. 33, No. 12. pp. 1039-1044.
@article{e5cafe94a46c4c9aba1fbcf21d85fe21,
title = "PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR",
abstract = "Endothelial dysfunction typical of preeclampsia (PE) is the result of an excessive maternal inflammatory response to pregnancy. We investigated PTX3 in maternal, fetal and placental compartments in complicated pregnancies. Maternal blood samples were collected during the third trimester in 53 PE, 43 IUGR (intrauterine growth restriction) and 50 normal pregnancies. Fetal samples were collected from the umbilical vein in 26 PE, 23 IUGR and 26 normal pregnancies at elective cesarean section. Pattern and site of expression of PTX3 were studied by immunohistochemistry (IHC) on placenta, decidual bed and maternal peritoneum. PE and IUGR pregnancies had significantly higher maternal PTX3 levels compared to normal pregnancies, with IUGR significantly lower than PE. Maternal peritoneum expressed a significantly higher signal in the endothelium of pathological compared to normal pregnancies. The maternal increase of PTX3 correlated with the severity of disease with higher PTX3 concentrations in severe PE. Increased PTX3 levels in PE and IUGR mothers, together with IHC data represent the expression of altered endothelial function on the maternal side. IUGR fetuses had higher PTX3 values than controls and the increase was related to IUGR severity, likely reflecting the hypoxic environment. These data confirm the relevance of PTX3 in support the hypothesis that PE is a disease associated with altered maternal endothelial function. The PTX3 increase in IUGR fetuses deserves further investigation.",
keywords = "Endothelial dysfunction, Fetus, Intrauterine growth restriction, Preeclampsia, PTX3",
author = "V. Cozzi and C. Garlanda and M. Nebuloni and V. Maina and A. Martinelli and S. Calabrese and I. Cetin",
year = "2012",
month = "12",
doi = "10.1016/j.placenta.2012.09.009",
language = "English",
volume = "33",
pages = "1039--1044",
journal = "Placenta",
issn = "0143-4004",
publisher = "W.B. Saunders Ltd",
number = "12",

}

TY - JOUR

T1 - PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR

AU - Cozzi, V.

AU - Garlanda, C.

AU - Nebuloni, M.

AU - Maina, V.

AU - Martinelli, A.

AU - Calabrese, S.

AU - Cetin, I.

PY - 2012/12

Y1 - 2012/12

N2 - Endothelial dysfunction typical of preeclampsia (PE) is the result of an excessive maternal inflammatory response to pregnancy. We investigated PTX3 in maternal, fetal and placental compartments in complicated pregnancies. Maternal blood samples were collected during the third trimester in 53 PE, 43 IUGR (intrauterine growth restriction) and 50 normal pregnancies. Fetal samples were collected from the umbilical vein in 26 PE, 23 IUGR and 26 normal pregnancies at elective cesarean section. Pattern and site of expression of PTX3 were studied by immunohistochemistry (IHC) on placenta, decidual bed and maternal peritoneum. PE and IUGR pregnancies had significantly higher maternal PTX3 levels compared to normal pregnancies, with IUGR significantly lower than PE. Maternal peritoneum expressed a significantly higher signal in the endothelium of pathological compared to normal pregnancies. The maternal increase of PTX3 correlated with the severity of disease with higher PTX3 concentrations in severe PE. Increased PTX3 levels in PE and IUGR mothers, together with IHC data represent the expression of altered endothelial function on the maternal side. IUGR fetuses had higher PTX3 values than controls and the increase was related to IUGR severity, likely reflecting the hypoxic environment. These data confirm the relevance of PTX3 in support the hypothesis that PE is a disease associated with altered maternal endothelial function. The PTX3 increase in IUGR fetuses deserves further investigation.

AB - Endothelial dysfunction typical of preeclampsia (PE) is the result of an excessive maternal inflammatory response to pregnancy. We investigated PTX3 in maternal, fetal and placental compartments in complicated pregnancies. Maternal blood samples were collected during the third trimester in 53 PE, 43 IUGR (intrauterine growth restriction) and 50 normal pregnancies. Fetal samples were collected from the umbilical vein in 26 PE, 23 IUGR and 26 normal pregnancies at elective cesarean section. Pattern and site of expression of PTX3 were studied by immunohistochemistry (IHC) on placenta, decidual bed and maternal peritoneum. PE and IUGR pregnancies had significantly higher maternal PTX3 levels compared to normal pregnancies, with IUGR significantly lower than PE. Maternal peritoneum expressed a significantly higher signal in the endothelium of pathological compared to normal pregnancies. The maternal increase of PTX3 correlated with the severity of disease with higher PTX3 concentrations in severe PE. Increased PTX3 levels in PE and IUGR mothers, together with IHC data represent the expression of altered endothelial function on the maternal side. IUGR fetuses had higher PTX3 values than controls and the increase was related to IUGR severity, likely reflecting the hypoxic environment. These data confirm the relevance of PTX3 in support the hypothesis that PE is a disease associated with altered maternal endothelial function. The PTX3 increase in IUGR fetuses deserves further investigation.

KW - Endothelial dysfunction

KW - Fetus

KW - Intrauterine growth restriction

KW - Preeclampsia

KW - PTX3

UR - http://www.scopus.com/inward/record.url?scp=84869504329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869504329&partnerID=8YFLogxK

U2 - 10.1016/j.placenta.2012.09.009

DO - 10.1016/j.placenta.2012.09.009

M3 - Article

C2 - 23062219

AN - SCOPUS:84869504329

VL - 33

SP - 1039

EP - 1044

JO - Placenta

JF - Placenta

SN - 0143-4004

IS - 12

ER -